Metropolis Healthcare Limited (METROPOLIS)
ISIN: INE112L01020 Industry: Diagnostics & Research Sector: Healthcare Website
1422.8
-36.75(-2.52%)

Metropolis Healthcare Limited provides diagnostic services in India. The company offers clinical laboratory testing, and profiles and support services to patients, smaller labs, nursing homes, and hospitals. It provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. The company's tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. It also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2021, the company operated 125 clinical laboratories, 9,000 pick-up points, and 498 assisted referral centers. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

1489

TODAY'S LOW

1421.2

52 WEEK HIGH

3579.9

52 WEEK LOW

1378.05

Major Holders

% of Shares Held by
All Insider

51.73%

% of Shares Held by
Institutions

28.45%

% of Float Held by
Institutions

58.93%

Number of Institutions
Holding Shares

61

Company Overview

MARKET CAP

7281.13 Cr.

ETERPRISE VALUE

7663.99 Cr.

NO. OF SHARES

5.11 Cr.

BOOK VALUE

173.288

DIV. YIELD

8%

DEBT

378.55 Cr.

GROSS PROFIT

952.31 Cr.

CASH

180.69 Cr.

REVENUE

1228.33 Cr.

REVENUE/SHARE

240.125

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-80.04 Cr.84.85 Cr.-60.63 Cr.57.08 Cr.
Change To Liabilities-16.50 Cr.23.44 Cr.31.63 Cr.7.51 Cr.
Total cashflows from Investing Activities-737.57 Cr.61.70 Cr.-104.83 Cr.35.34 Cr.
Net Borrowings220.93 Cr.-17.98 Cr.-31.07 Cr.17.04 Cr.
Total Cash from Financing Activities162.52 Cr.-32.69 Cr.-55.32 Cr.-118.14 Cr.
Other Liabilities-3.54 Cr.-6.13 Cr.21.22 Cr.-12.09 Cr.
Total Assets1.97 Cr.34.31 Cr.31.89 Cr.2.57 Cr.
Net Income214.18 Cr.183.09 Cr.127.32 Cr.120.14 Cr.
Change in Cash-320.61 Cr.279.41 Cr.55.80 Cr.7.90 Cr.
Effect of Exchange Rate-1.36 Cr.1.37 Cr.95.68 Lakhs55.66 Lakhs
Total Cash from Operating Activities253.27 Cr.249.02 Cr.215 Cr.90.15 Cr.
Depreciation63.22 Cr.41.03 Cr.37.01 Cr.18.48 Cr.
Other Cashflows from Investing Activities11.06 Cr.10.43 Cr.4.12 Cr.3.02 Cr.
Dividends Paid-40.93 Cr.-40.89 Cr.-40.14 Cr.-66.53 Cr.
Change to Inventory-7.93 Cr.-16.14 Cr.1.70 Cr.-4.91 Cr.
Change to Account Receivables11.58 Cr.-16.46 Cr.-26.58 Cr.-41.28 Cr.
Other Cashflows from Financing Activities-19.44 Cr.-8.13 Cr.-16 Cr.-71.22 Cr.
Change to Net Income-7.73 Cr.35.29 Cr.20.43 Cr.71.85 Lakhs
Capital Expenditures-30.66 Cr.-28.27 Cr.-29.18 Cr.-19.55 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research Development6.90 Cr.5.44 Cr.6.88 Cr.5.57 Cr.
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax293.35 Cr.244.32 Cr.168.73 Cr.186.55 Cr.
Minority Interest1.96 Cr.1.46 Cr.1.65 Cr.1.43 Cr.
Net Income279.56 Cr.242.34 Cr.194.15 Cr.183.09 Cr.
Selling General Administrative233.17 Cr.274.64 Cr.256.71 Cr.248.36 Cr.
Gross Profit952.31 Cr.727.78 Cr.639.12 Cr.576.39 Cr.
Ebit279.56 Cr.242.34 Cr.194.15 Cr.183.09 Cr.
Operating Income279.56 Cr.242.34 Cr.194.15 Cr.183.09 Cr.
Other Operating Expenses369.44 Cr.159.39 Cr.142.09 Cr.119.04 Cr.
Interest Expense-19.74 Cr.-7.78 Cr.-8.34 Cr.-53.11 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense78.66 Cr.60.97 Cr.41.18 Cr.62.93 Cr.
Total Revenue1228.33 Cr.997.98 Cr.856.40 Cr.761.18 Cr.
Total Operating Expenses948.76 Cr.755.63 Cr.662.24 Cr.578.08 Cr.
Cost of Revenue276.02 Cr.270.20 Cr.217.27 Cr.184.79 Cr.
Total Other Income Expense Net13.78 Cr.1.97 Cr.-25.42 Cr.3.45 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.214.68 Cr.183.34 Cr.127.55 Cr.123.61 Cr.
Net Income Applicable to Common Shares214.18 Cr.183.09 Cr.127.32 Cr.120.14 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets361.29 Cr.34.59 Cr.28.15 Cr.23.35 Cr.
Capital Surplus0153.08 Cr.118.86 Cr.87.05 Cr.
Total Liabilities642.12 Cr.296.34 Cr.227.07 Cr.132.67 Cr.
Stock Holder Equity886.19 Cr.706.60 Cr.523.49 Cr.418.53 Cr.
Minority Interest1.96 Cr.1.46 Cr.1.65 Cr.1.43 Cr.
Other Liabilities52.22 Cr.36.37 Cr.28.83 Cr.28.68 Cr.
Total Assets1530.29 Cr.1004.41 Cr.752.23 Cr.552.64 Cr.
Common Stock10.23 Cr.10.22 Cr.10.12 Cr.10.03 Cr.
Retained Earnings0531.29 Cr.390.33 Cr.315.83 Cr.
Other Liabilities99.27 Cr.13.46 Cr.11.82 Cr.8.14 Cr.
Good Will454.68 Cr.90.25 Cr.90.34 Cr.78.55 Cr.
Treasury Stock875.96 Cr.12 Cr.4.17 Cr.5.60 Cr.
Other Assets35.96 Cr.50.98 Cr.53.47 Cr.26.95 Cr.
Cash166.93 Cr.386.59 Cr.107.17 Cr.51.37 Cr.
Current Liabilities301.54 Cr.203.95 Cr.169.47 Cr.124.48 Cr.
Long Term Asset Charges9.78 Cr.17.08 Cr.13.90 Cr.3.65 Cr.
Short Long Term Debt003.51 Lakhs16.55 Lakhs
Other Stockholder Equity875.96 Cr.12 Cr.4.17 Cr.5.60 Cr.
Property Plant Equipment248.72 Cr.218.26 Cr.180.85 Cr.116.67 Cr.
Total Cur. Assets393.12 Cr.608.45 Cr.397.05 Cr.304.72 Cr.
Long Term Investments36.50 Cr.1.86 Cr.2.33 Cr.2.37 Cr.
Net Tangible Assets70.21 Cr.581.75 Cr.404.99 Cr.316.62 Cr.
Short Term Investments13.75 Cr.25.50 Cr.86.27 Cr.11.84 Cr.
Net Receivables147.01 Cr.127.70 Cr.141.59 Cr.160.38 Cr.
Long Term Debt158.67 Cr.003.51 Lakhs
Inventory51.10 Cr.40.54 Cr.24.40 Cr.26.10 Cr.
Accounts Payable103.20 Cr.110.55 Cr.85.03 Cr.42.84 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account